# OmicXScreen

Source: https://onco.cc/drugs/omicxscreen/  
OnCo record `omicxscreen` (Test). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

OmicXScreen is an investigational blood test from OmicXHealth that reads DNA patterns to look for early liver cancer, with other cancers in development.

## Summary

OmicXScreen is the early cancer detection platform of OmicXHealth. The company reports preclinical validation for hepatocellular carcinoma, a lung cancer classifier and proof of concept in six cancer types. The National Cancer Institute funds an SBIR project on the test for early hepatocellular carcinoma and oesophageal cancer detection (1R43CA310377-01A1). It is not cleared or approved by a regulator.

## Fields

- Kind: Test
- Status: emerging
- Last checked: 2026-11-04
- Tags: pipeline
- Modality: Blood test (whole-genome sequencing with DNA methylation analysis and machine learning)
- Mechanism: Sequences cell-free DNA from a blood sample once across the whole genome and analyses methylation patterns in software with machine-learning models to detect early cancer.

## Sources

- OmicXHealth: https://www.omicxhealth.com/
- NIH RePORTER: 1R43CA310377-01A1: https://reporter.nih.gov/project-details/11404601

## Connected records

- technologies: [Cell-free DNA methylation tests](https://onco.cc/technologies/cfdna-methylation-testing/)
- companies: [OmicXHealth](https://onco.cc/companies/omicxhealth/)

---
JSON: https://onco.cc/api/v1/entities/omicxscreen.json